Search Through Grants for HIV / AIDS in the U.S.

Who We Are

The Creag Foundation is a private grant making foundation established in 2009 in Woodinville, Washington.

The founders of the Creag Foundation believe that meaningful change can only be achieved through hard work, creativity and passion. They also understand the practical mechanisms that allow charitable organizations to succeed and grow. As a group, Creag Foundation principals are dedicated to helping today’s most innovative programs improve the human condition in a wide variety of ways.

Our Focus

The broad purpose of the Foundation is to support the efforts of nonprofit organizations who are innovators in the field of human services. Our particular focus is on smaller organizations that are starting out or established organizations that are looking for funding to take their organization in a new direction.

What We Fund

/ What We Fund

The Creag Foundation is focused on innovation in the industry. We will consider proposals from 501(c)(3) organizations that are finding new ways to address societal issues facing the nonprofit community. Applicants must have held 501(c)(3) status for one year before submitting. If your organization has held 501(c)(3) status for over a year, and your believe that your organization has a new approach to an existing social problem or is addressing a previously unaddressed social issue, you are welcome to contact us and request that we consider your organization for a funding opportunity.

Mission

The DanPaul Foundation will use its resources to help train teachers and parents in early childhood development, protect children from abuse and neglect, stimulate children's personal social responsibilities, and offer them opportunities for enrichment and growth.

The Foundation will also encourage children to be concerned and informed about the environment and the underprivileged, particularly with regard to clean air and water, and adequate housing and nutrition for all.

Beliefs

The DanPaul Foundation believes that children should have ample opportunities for enrichment in their lives, and thus strives to provide many different ways to enrich and expand children's minds through direct programs and monetary support to organizations doing similar work.

We have provided or currently provide grants related to the following program areas:

• Workshops, Conferences, + Seminars: We strive to offer educational workshops, conferences, and seminars for parents and teachers on topics related to early childhood development.
• Student Scholarships: We aim to help students attending post-secondary education institutions by providing need-based and academic scholarships.
• Scientific Endeavors: We desire to advance scientific endeavors which seek to improve the quality of life for everyone in the world.
• Clean Air + Water: We hope to pass on knowledge and practical life skills to youth regarding their personal responsibility to the environment, teaching them about issues surrounding clean air and water.
• Child Advocacy: We believe in protecting children from abuse and neglect and particularly love to support programs that provide education and assistance to children as well as organizations advocating or caring for vulnerable children.
• Homelessness: We want to encourage young people to take a personal interest in seeing that adequate housing and proper nutrition, especially for the underprivileged and homeless, are available.
• Poverty + Neglect: We seek to help those in poverty as well as educate youth about their responsibility to consider the underprivileged and take care of those most in need of life's basic essentials like adequate housing and proper nutrition.
• Refugee Enrichment: We wish to help refugee youth by supporting programs that provide them enrichment and help them transition to life in a new country.

The DanPaul Foundation provides grants to 501(c)3 tax-exempt non-profit organizations as defined by the IRS. The Foundation is interested in providing funding to programs that directly serve the health, education, development, and welfare of the world's youth.

Grants range from a few hundred dollars up to $15,000 per calendar year.

What We Fund

We support community-informed, data-driven programs that strengthen healthcare infrastructures and provide education and financial support to the most vulnerable communities around the world. Our corporate giving programs focus support where the need is greatest and we prioritize applications that demonstrate a strong capability to deliver the specific outcomes the grant would support.

We welcome funding requests for innovative, high-impact projects that relate to at least one of our core therapeutic areas:

• HIV
• Liver disease
  • Hepatitis C
  • Hepatitis B
  • Hepatitis D
  • Primary biliary cholangitis
• Oncology
  • Hematology
  • Solid tumors
• Chronic Inflammatory Diseases

Types of Support

Patient Community Support:

We strive to advance health equity, diversity in clinical trials and access to medicines to reduce disparities. We also support the local communities in which we operate.

• Examples of Patient Community Support projects Gilead has funded include:
  • Events or resources to educate patients about prevention and care options, such as:
    • Presentations
    • Web-based resources
    • Printed materials
    • Testing and screening initiatives
• The types of Patient Community Support organizations Gilead has funded include:
  • Patient advocacy and support groups
  • Hospitals and clinics
  • Nonprofit service organizations
  • Professional associations
  • Academic medical centers and universities

Corporate Sponsorships:

Many individuals face barriers to accessing healthcare due to age, disability, ethnicity or race, location, gender, gender identity or socioeconomic status.

To help ensure all people have the opportunity to get the best possible care – regardless of background – Gilead sponsors select events or conferences that raise awareness and support organizations working in our therapeutic areas of focus.

Events Gilead has sponsored include:

• Walks/runs
• Awards dinners
• Fundraising galas
• Community conferences

Gilead North America Grants

We are inspired by the work that our grantees do every day to improve access and eliminate barriers to healthcare while advancing education among patients and healthcare professionals. We support projects in North America across all our therapeutic areas — HIV, liver diseases, oncology and inflammatory and respiratory diseases.

Funding Priorities

• HIV:
  • While advances in medical research help millions of people living with HIV have longer, more fulfilling lives today, HIV continues to have a devastating impact, especially on underserved communities and in populations who lack access to medical care and are impacted by stigma and discrimination. We support organizations working to help individuals learn their HIV status and get the care they need. We also support organizations that aim to solve the challenges of tomorrow, including how to:
    • Understand the impact HIV has on an aging population
    • Ensure continuity and retention in care
    • Spark appreciation for innovative thinking in HIV treatment
    • Identify and create a new generation of advocates
• HIV Cure:
  • We work to address the HIV epidemic by discovering transformative and life-saving medicines, developing simplified treatment regimens that increase efficacy, expanding access to treatment for those who need it most and building communities among people affected by HIV and AIDS. Continuing on this commitment, we partner with and support institutions, community groups and organizations that are engaged in HIV cure activities through grant funding.
• HIV Prevention:
  • We support the efforts of community-based organizations, public health entities and similar nonprofit organizations to educate their constituents about comprehensive HIV prevention, including the role of pre-exposure prophylaxis (PrEP). Specifically, we support programs designed to:
    • Provide comprehensive education on the range of prevention options and strategies available
    • Ensure biomedical prevention plans, such as PrEP, are implemented safely and effectively in accordance with recommended guidelines
    • Engage communities and individuals at highest risk for HIV infection in prevention efforts
• Liver Disease:
  • Hepatitis C disproportionately affects people who use drugs and other at-risk populations and there remain gaps in access to testing and care. We are working to change this by providing funding for organizations that:
    • Raise awareness and provide education
    • Increase treatment capacity and sustainability
    • Move individuals down the care pathway from screening to cure
    • Eliminate barriers to testing, care and treatment
• Oncology: Cancer remains one of the greatest health challenges we face. We support organizations focused on health equity in order to: 
  • Enable people affected by cancer and their caregivers to make informed health decisions
  • Educate healthcare providers on identification, screening and diagnosis
  • Improve access to prevention and treatment by overcoming barriers to care
• Inflammatory and Respiratory Diseases: Inflammatory and respiratory diseases have a substantial impact on people of every age, gender, ethnic group and economic class. We fund organizations that work in this therapeutic area to:
  • Improve individuals’ health literacy, enabling them to make informed health decisions
  • Educate healthcare providers on identification, screening and diagnosis
  • Improve access to treatment by overcoming financial and other obstacles

Funding

Gilead doesn’t place a limit on how much grantees can apply for. We want you to request the level of funding that you’ll need to make your project a success.

About

Robert Mapplethorpe established the Robert Mapplethorpe Foundation on May 27, 1988, the year before his death, to protect his work, to advance his creative vision and to promote the causes he cared about. Serving as the first president of its board of trustees, he established two mandates: to promote photography as an art form in order to achieve its recognition and respect at the same level as painting and sculpture; and to support HIV/AIDS medical research. In keeping with Mapplethorpe's wishes, The Robert Mapplethorpe Foundation continues to support photography programming at both major museums as well as small institutions for exhibitions, acquisitions, and publications.

In 1993, the Foundation provided an historic gift to the Solomon R. Guggenheim Foundation to create the named Robert Mapplethorpe Gallery and to inaugurate the Guggenheim Museum's photography program. In addition to its financial component, the Foundation made a gift of more than 200 of the artist’s works, selected by the Museum.

The Foundation subsequently awarded three major gifts supporting photography programs which resulted in galleries or facilities permanently named for Robert Mapplethorpe—at the Whitney Museum of American Art, the Hessel Museum of Art at Bard College, in Annandale-on-Hudson, NY, and the National Portrait Gallery, part of the National Galleries of Scotland in Edinburgh. In addition to the Guggenheim Museum, significant public collections of Mapplethorpe’s work may be found in the Artist Rooms Collection jointly owned by the Tate Modern, London and the National Galleries of Scotland; at the Museum of Modern Art, New York; the Hessel Museum of Art; and the Kinsey Institute at Indiana University.

In 2011, the Mapplethorpe Foundation donated its archive to the Getty Research Institute and gave an encyclopedic collection of artworks to the J. Paul Getty Museum in partnership with the Los Angeles County Museum of Art. This gift established a comprehensive archive and collection available to scholars.

In its early years, the Foundation prioritized its focus on HIV and AIDS medical research. It created important medical facilities and programs, including the Robert Mapplethorpe Laboratory for AIDS Research at Harvard Medical School in Boston, the Robert Mapplethorpe Residential Treatment Facility at Beth Israel Medical Center in New York, and the Robert Mapplethorpe Center for HIV Research at St. Vincent's Hospital, New York. The Foundation provided substantial financial support to the American Foundation for AIDS Research (amfAR). The Foundation continues to support research initiatives and has provided funds to amfAR, distinguished institutions such as the Rockefeller University, and community-based experimental treatment organizations, including the AIDS Community Research Initiative of America (ACRIA).

The Foundation is dedicated to protecting and expanding Mapplethorpe’s artistic legacy by encouraging museum exhibitions internationally. It publishes books and places his artworks from its considerable inventory in important public and private collections around the world.

Photography Grant

The Robert Mapplethorpe Foundation provides support for museums and other public institutions to expand photography programming, including acquisitions, exhibitions, and publications. As the beneficiary of Robert Mapplethorpe’s Estate, the Foundation has made contributions in the form of artworks or gifts of money to qualifying applicants. In the appropriate circumstance, the Foundation will also assist independent curators in developing interesting photography exhibitions.

Philanthropy is our commitment to communities in which we operate and broader society. We focus our resources on a limited number of key projects that can deliver valuable benefits from our contributions and those of our partners. We give priority to innovative, high-quality projects that meet the following criteria:

• promote sustainable development
• offer an opportunity for Roche to use its expertise and logistics capabilities
• involve Roche actively at an early stage with local authorities and established partners
• engage Roche employees in cultural (focus on contemporary arts), educational and social activities
• managed by an accredited charity

Our four focus areas

Humanitarian and Social

We direct the majority of our philanthropic donations to humanitarian and social development projects.

Science and education

We are dedicated to programmes that promote scientific interest and provide educational opportunities for young people around the world.

Community and Environment

We are committed to building stronger communities and responding to natural disasters sustainably.

Arts and Culture

We support groundbreaking contemporary art, cultural projects and activities that explore the parallels between innovation in art and in science. 

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives: 

• Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and
• Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.

The purpose of this reissuance is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Max and Victoria Dreyfus Foundation Grant

The Foundation will consider requests to support museums, cultural and performing arts programs; schools and hospitals; educational, skills-training and other programs for youth, seniors, and persons with disabilities; environmental and wildlife protection activities; and other community-based organizations and programs.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas:

• the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and
• pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.

In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

The goal of Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care is to strengthen collaboration between RWHAP Parts in specific jurisdictions through an objective process with a focus on the ending the HIV epidemic in that jurisdiction. Through this project RWHAP recipients will develop actions tailored to the specific needs of the out-of-care population(s) in their specific communities, enhance existing collaborations and build new ones that maximize resources, and strengthen the overall systems of care.

In support of reaching goals that jurisdictions have set through their Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need (SCSN), local ending the HIV epidemic work and other planning efforts, this project will fund one technical assistance (TA) provider to plan and coordinate a state convening of Ryan White HIV/AIDS Programs Parts A, B C, D, and Part F-AIDS Education and Training Centers (AETCs) in eight states to develop an action plan to reach people with HIV who are not engaged in HIV care. The TA provider will develop a comprehensive asset map of resources and potential new partners for each state that can be leveraged to address the out-of-care population. The TA provider will organize and facilitate meetings with all the RWHAP Parts in each state using a tailored approach to best meet the needs of local recipients; this may include virtual preparatory meetings in addition to the in-person statewide meeting. Key state-level officials, such as the state health officers, will be invited to participate in the state-wide meetings to engage their support. With the assistance of the TA provider, participants will develop an action plan with concrete steps to reach people with HIV that are out of care and engage them in sustained HIV care. States will be identified based on unmet need data with a focus on states that are not receiving Ending the HIV Epidemic in the U.S. initiative (EHE) funds. Addressing unmet need for care and treatment and increasing viral suppression helps to reduce HIV transmission as people who are virally suppressed cannot transmit HIV to their sexual partners. This is important as 87 percent of new HIV infections come from people with HIV who have not yet been successfully engaged in care.

The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Breeding colonies are essential to sustain appropriate SPF macaques for research related to HIV/AIDS. Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility complex (MHC) class I types, because MHC class I genotypes have large effects on macaque immune responses to Simian Immunodeficiency Virus (SIV) that can induce AIDS in nonhuman primates (NHPs) and on human immune responses to HIV.

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:

• Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and
• Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:

• Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and
• Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues are important for developing strategies for long-term viral suppression or eradication. Finally, health-impeding social determinants of health may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.

Positive Action Community Grants

ViiV Healthcare was established to take an innovative approach to the challenge of HIV—and we do. It’s who we are. An innovative approach means we go beyond developing new medicines—we know it takes more to end the epidemic.

Through a combination of community-focused approaches that include deep listening, grantmaking, community engagement, shared learning, and cultural arts programs, we ensure that the voices of the HIV community inform everything we do.

Focus

Our approach to giving has always been about more than money. We Listen. Seeking insights and understanding to foster collaboration and action. We Activate new initiatives and fund community projects where there are the greatest disparities, while connecting individuals and organizations to strengthen networks and services. We Amplify. Sharing insights to illuminate bright spots and drive community solutions. We Sustain. Strengthening leaders, organizations, and communities to build and expand on the momentum of effective work. Through this approach we focus our funding and collaborations on community organizations that are prioritizing work in three key focus areas:

Networks

Strengthen supportive networks for people living with an impacted by HIV and those who serve them

Linkage & Engagement

Support navigation and programs that help link, re-link, and engage people in HIV prevention, treatment, and care

Advocacy

Amplify the efforts of people living with and impacted by HIV to advocate for themselves, strengthen leadership, insights, and culture activities that reduce stigma, and fuel community responses.

Funding

ViiV Healthcare’s Positive Action Community Grants (PACG) initiative is currently requesting proposals to support:

• The health and well-being of people living with HIV through innovative, community-led solutions that address disparities in the epidemic, and;
• Strong prevention infrastructure for communities of color, fueling new ways to reach and engage people in HIV prevention, shift the narrative around risk, and fuel networks that help disrupt disparities in HIV prevention.

Organizations applying to Positive Action Community Grants may request funding in the following three categories:

• General operating support for core support and mission-driven community-based work.
• Special events sponsorships for conferences and events that foster networks, create awareness, and amplify the voices of people living with HIV and AIDS.
• Project support for organizations implementing innovative projects within ViiV Healthcare’s focus areas: linkage to care, networks of support, and advocacy. ViiV Healthcare is particularly interested in efforts that operate at the intersection of HIV, stigma, and other social determinants of health in the following ways:
  • Expanding harm reduction services and advocacy to successfully engage people who use drugs in care, and support their families and communities;
  • The decriminalization of HIV at the local and national level;
  • Increasing access to quality and culturally responsive sexual health education;
  • Activating arts and culture as a tool for community engagement, connection, and building empathy;
  • Increasing access to and awareness of the mental health needs of people living with or vulnerable to HIV.

The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

The Foundation for AIDS Research

amfAR’s mission is to end the global AIDS epidemic through innovative research

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested more than $635 million in its programs and has awarded more than 3,500 grants to research teams worldwide.

Mathilde Krim Fellowships in Biomedical Research

Goals

The goal of amfAR’s Mathilde Krim Fellowships in Biomedical Research is to:

• Facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic institution or nonprofit organization
• Support two years of postdoctoral biomedical research (phase I)
• Provide the possibility of one additional year of research funding during the first year of an independent research position at an academic institution or nonprofit organization (phase II)

Funding Principles

A major priority of amfAR’s research program is discovering the scientific basis of a cure for HIV. The urgency of our goal demands that we direct our funding to studies that uncover vital knowledge that is directly applicable to curing HIV in people living with HIV/AIDS.

In determining research priorities, amfAR considers the availability of funding, the current scope of knowledge, and whether the research is necessary and sufficient to accomplish our goal.

Questions such as those below guide amfAR’s consideration of research proposals:

• Is the proposed research addressing a fundamental question that would propel several cure-focused approaches forward with the answer?
• How strong is the evidence that the overall approach has the potential to cure HIV?
• Do we already have sufficient answers to this research question?
• Would it be possible to develop a cure for HIV without the knowledge the researcher is seeking to acquire?
• Are personnel numbers and costs appropriate?

Funding

Maximum Funding: $180,000 including maximum 15% indirect costs

Phase II funding for an additional $50,000 may be approved, at a later date, to support biomedical HIV/AIDS research costs during the first 12 months of an independent research position at any US or international nonprofit research institution.

Phase II funding can start any time during the Phase I performance period, or up to six months following the end of the Phase I period.

About the Foundation

Jesse W. Couch lived a life of zeal, honor, and dedication to the betterment of his community. The Couch family now humbly stewards the foundation he created to carry on his legacy of service for future generations. We believe that impact is best accomplished through partnerships with local organizations that know the people and communities they serve. We invest in and support efforts to protect the environment, further conservation and preservation initiatives, and save historical architecture that preserves community heritage. We also support initiatives that promote wellness and mental health and organizations seeking to provide and further education for all communities.

Annual Grant Focus

Each year, we seek to partner with and support non-profit organizations making an impact in the focus areas listed here.  The focus areas for 2025 are:

• Animal Wellbeing: We are dedicated to helping nonprofit organizations that nurture compassion and respect for all living animals. We must have animal-focused organizations that advocate for animal rights and provide humane treatment across all spectrums.
• Early Childhood Education: We are looking for schools that are providing young children with a creative and balanced approach to education. Things we love in early childhood curriculums:
  • Life Skills
  • Collaboration With Their Peers and Teachers   
  • Having Fun   
  • Montessori Teachings   
  • Project Based Teachings   
  • Diversity   
  • More Time Outside   
  • Less Screen Time
• Teachers: Teachers are essential to providing children with the best possible education. We must invest in their future and are always looking for teams that help them succeed in educating future generations.
• Get Outside: Being outside can improve memory, fight depression, lower blood pressure, and more! We support organizations that facilitate and encourage more outdoor activities that help create healthier communities. 

The Lawrence Foundation is a private family foundation focused on making grants to support environmental, human services and other causes.

The Lawrence Foundation was established in mid-2000. We make both program and operating grants and do not have any geographical restrictions on our grants. Nonprofit organizations that qualify for public charity status under section 501(c)(3) of the Internal Revenue Code or other similar organizations are eligible for grants from The Lawrence Foundation.  

Grant Amount and Types

Grants typically range between $5,000 - $10,000. In some limited cases we may make larger grants, but that is typically after we have gotten to know your organization over a period of time. We also generally don’t make multi-year grants, although we may fund the same organization on a year by year basis over a period of years.

General operating or program/project grant requests within our areas of interests are accepted. In general, regardless of whether a grant request is for general operating or program/project expenses, all of our grants will be issued as unrestricted grants.

True Inspiration Awards

The True Inspiration Awards® program was created in 2015 to honor the legacy of Chick-fil-A® founder S. Truett Cathy. Through these annual grants, it is our pleasure to celebrate and support nonprofit organizations making an impact in their local communities.

S. Truett Cathy Honoree

One organization will be selected as the S. Truett Cathy Honoree. The S. Truett Cathy Honoree embodies the generous, innovative spirit of Chick-fil-A’s late founder — pioneering new ways to solve problems and serve others.

Category winners

In 2025 we will continue to support nonprofits with a total commitment of $6 million in grants ranging from $30,000-$350,000.

Sixteen organizations will be awarded for their work in these areas.

Caring for People (four winners): Programs or projects supporting educational initiatives, including fostering character and leadership development, academic excellence and community involvement in underserved youth.

Caring through Food (four winners): Programs or projects focused on addressing hunger and food insecurity facing children and their families.

Community (four winners): Programs or projects focused on providing housing and other direct services to support young people and their families.

Caring for our Planet (four winners): Programs or projects that show care for our environment and our planet, or that demonstrate environmental stewardship through initiatives directly related to our other True Inspiration Awards categories of food, community and people (i.e., community beautification, education opportunities, community gardens, outdoor classrooms, etc.) 

Community Partnership Award

The Mutual of America Foundation Community Partnership Award recognizes outstanding nonprofit organizations in the United States that have shown exemplary leadership by facilitating partnerships with public, private or social sector leaders who are working together as equal partners, not as donors and recipients, to build a cohesive community that serves as a model for collaborating with others for the greater good.

Each year, the Mutual of America Foundation sponsors a national competition in which hundreds of organizations demonstrate the value of their partnership to the communities they serve, their ability to be replicated by others and their capacity to stimulate new approaches to addressing significant social issues.

Six organizations are selected by an independent committee to receive the Community Partnership Award.

• The Thomas J. Moran Award is given to the national award-winning program and includes $100,000 and a documentary video about the program.
• The Frances R. Hesselbein Award is given to a partnership that is addressing social challenges in more than one community, or which demonstrates the potential to be replicated in other communities. This recipient receives $75,000.
• Four other organizations are named Honorable Mention recipients for their programs, and each receives $50,000.

Since its inception in 1996, the Community Partnership Award has recognized 262 partnerships from cities and towns across America. Like so many of our clients working in the nonprofit community, Mutual of America is dedicated to having a direct, positive impact on society.

Mission

AIDS United’s mission is to end the HIV epidemic in the United States.

In the ongoing work for social justice and true equity, ending the HIV epidemic in the United States is our chosen role. We’ve seen firsthand how the intersectionality of social injustice, discrimination and health care disparity impacts those living with HIV, and we believe alleviating this struggle is a pivotal step toward our national well-being.

Vision

AIDS United envisions a time when all people, governments, and organizations commit to ending the epidemic and strengthening the health, well-being, and human rights of everyone impacted by HIV.

Harm Reduction Futures Fund

The Harm Reduction Futures Fund (formerly the Syringe Access Fund) is a collaborative grantmaking initiative that seeks to reduce the health, psychosocial, and socioeconomic disparities experienced by people who use drugs (PWUD). The Harm Reduction Futures Fund invests in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts, and connect people who use drugs to comprehensive prevention, treatment, and support services.

The Harm Reduction Futures Fund will award grants this Round to three kinds of organizations:

• syringe services programs providing direct services,
• harm reduction organizations supporting multiple syringe service programs providing direct services

Please note, we are currently not offering advocacy grants. At this time only direct service applications will be accepted. 

Purpose

The primary goal of the Harm Reduction Futures Fund is to provide core support for programs that demonstrate:

• an ability to provide high quality syringe and other drug user health services to one or more identified communities

The Harm Reduction Futures Fund seeks to identify and support organizations across intersecting movements to enhance and coordinate services for people who use drugs. It supports and funds organizations that are led by and/or meaningfully involve and serve networks of people who use drugs, including in the design, delivery, and evaluation of services. In Round 16, the Harm Reduction Futures Fund will prioritize support for programs that are led by and serve Black, Indigenous, and other People of Color (BIPOC), as well as those in jurisdictions of high need and low resources. Other compelling factors may include the leadership of current or former sex workers; prevalence of HIV, viral hepatitis, and other blood-borne pathogens in a community; injection drug use prevalence; opioid use; overdose incidence; availability of local funding.

Funding

AIDS United expects to provide one-year cash grants to a total cohort of  7 to 15 organizations.

• Direct Service organizations are invited to submit proposals for $10,000 to $25,000 for one year.
  • AU anticipates 5-13 programs will receive funding
• Multi-Program Support organizations are invited to submit proposals for $25,000 to $40,000 for one year.
  • AU anticipates 1 program will receive funding

Gupta Family Foundation is a private, nonprofit foundation headquartered in Herndon, Virginia, USA. Our mission is to support organizations that provide focused intervention in the lives of people who have been disadvantaged in some way to help them become self-reliant. We take a very broad view of “disadvantage” to include anything that holds a person back from realizing their potential, such as poverty, physical or mental disability, social alienation, etc. The foundation also supports relief agencies that serve people affected by emergencies such as natural disasters.

The foundation evaluates and awards annual and multi-year grants ranging from $5,000 to over $250,000 (USD). Our focus is on funding smaller organizations all around the world that are led by individuals with a deep personal commitment to their missions. 

Our selection criteria include:

• Mission alignment
• The organization is run by the founder or, if not, by a successor who embodies the original inspiration, passion and commitment of the founder.
• At least 90% of grant monies reaches the intended beneficiaries.
• The organization is non-sectarian, i.e.,
  • It does not, directly or indirectly, support or condone the proselytization of any religion,
  • It is not supported by or affiliated to a religious organization.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Mental Health (NIMH) R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and advance the priorities outlined in the Office of AIDS Research (OAR) Annual Strategic Plan and the research program priorities of the NIMH Division of AIDS Research (DAR).

To accomplish the stated over-arching goal, this NOFO will support creative educational activities with a primary focus on Research Experiences and Mentoring Activities that either capitalize on existing networks of collaborating investigators or develop institute-based research education programs. Both research experiences and mentoring activities are required; research experiences are expected to be primary. Research Education Programs are expected to enhance the professional development of the participants and foster a career trajectory towards independent research in the mental health of HIV/AIDS.

Our Mission

The Hansen Family Foundation provides opportunities to domestic, international, secular, and non-secular organizations that support the American way of life, which is defined by the principles of “life, liberty, and the pursuit of happiness.” 

Causes

Children

The Hansen Family Foundation supports causes dedicated to helping children both home as well as abroad. Learn More

Education

The Hansen Family Foundation believes that a decent education should be made available to everyone, young or old, the world over. Learn More

Animals

The Hansen Family Foundation believes in helping those who cannot speak on their own behalf. Learn More

Environmental

The Hansen Family Foundation is dedicated to preserving the world we all share. Learn More

Humanitarian

The Hansen Family Foundation views the plight of our fellow man as an opportunity to actively engage and effect change. Learn More

Arts & Culture

The Hansen Family Foundation supports all forms of artistic and cultural endeavors. Learn More